INFUSYSTEM HOLDINGS, INC Sales Revenue, Goods, Net (Deprecated 2018-01-31)
INFUSYSTEM HOLDINGS, INC (INFU) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $9.99 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-19
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.04M, a 50.74% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.27M, a 12.37% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.17M, a 15.52% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $2.52M, a 39.37% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $9.99M, a 20.57% increase from fiscal 2016.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $8.29M, a 9.20% increase from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $7.59M, a 2.32% decline from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $7.77M, a 22.97% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $5.30M derived: sum of 2 quarters · filed 2018-03-19 | $7.47M derived: sum of 3 quarters · filed 2018-03-19 | $9.99M 10-K · filed 2018-03-19 |
| 2017-09-30 | $2.27M 10-Q · filed 2017-11-13 | $4.44M derived: sum of 2 quarters · filed 2017-11-13 | $6.96M 10-Q · filed 2017-11-13 | $8.97M derived: sum of 4 quarters · filed 2018-03-19 |
| 2017-06-30 | $2.17M 10-Q · filed 2017-08-09 | $4.69M 10-Q · filed 2017-08-09 | $6.70M derived: sum of 3 quarters · filed 2018-03-19 | $9.29M derived: sum of 4 quarters · filed 2018-03-19 |
| 2017-03-31 | $2.52M 10-Q · filed 2017-05-15 | $4.53M derived: sum of 2 quarters · filed 2018-03-19 | $7.12M derived: sum of 3 quarters · filed 2018-03-19 | $9.00M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $4.60M derived: sum of 2 quarters · filed 2018-03-19 | $6.48M derived: sum of 3 quarters · filed 2018-03-19 | $8.29M 10-K · filed 2018-03-19 |
| 2016-09-30 | $2.59M 10-Q · filed 2017-11-13 | $4.47M derived: sum of 2 quarters · filed 2017-11-13 | $6.27M 10-Q · filed 2017-11-13 | $8.88M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $1.88M 10-Q · filed 2017-08-09 | $3.69M 10-Q · filed 2017-08-09 | $6.29M derived: sum of 3 quarters · filed 2017-08-09 | $8.14M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $1.81M 10-Q · filed 2017-05-15 | $4.41M derived: sum of 2 quarters · filed 2017-05-15 | $6.25M derived: sum of 3 quarters · filed 2017-05-15 | $7.81M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $4.45M derived: sum of 2 quarters · filed 2017-03-22 | $6.00M derived: sum of 3 quarters · filed 2017-03-22 | $7.59M 10-K · filed 2017-03-22 |
| 2015-09-30 | $1.84M 10-Q · filed 2016-12-12 | $3.40M derived: sum of 2 quarters · filed 2016-12-12 | $4.98M 10-Q · filed 2016-12-12 | $6.67M derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-06-30 | $1.55M 10-Q/A · filed 2016-12-12 | $3.14M 10-Q/A · filed 2016-12-12 | $4.83M derived: sum of 3 quarters · filed 2016-12-12 | $6.94M derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | $1.59M 10-Q/A · filed 2016-12-12 | $3.28M derived: sum of 2 quarters · filed 2016-12-12 | $5.39M derived: sum of 3 quarters · filed 2016-12-12 | $6.96M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | $1.69M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | $3.80M derived: sum of 2 quarters · filed 2016-12-12 | $5.38M derived: sum of 3 quarters · filed 2016-12-12 | $7.77M 10-K/A · filed 2016-12-12 |
| 2014-09-30 | $2.11M 10-Q · filed 2015-11-12 | $3.69M derived: sum of 2 quarters · filed 2015-11-12 | $6.08M 10-Q · filed 2015-11-12 | $8.85M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $1.58M 10-Q · filed 2015-08-13 | $3.97M 10-Q · filed 2015-08-13 | $6.74M derived: sum of 3 quarters · filed 2015-08-13 | $7.99M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $2.39M 10-Q · filed 2015-05-12 | $5.16M derived: sum of 2 quarters · filed 2015-05-12 | $6.41M derived: sum of 3 quarters · filed 2015-05-12 | $7.45M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $4.02M derived: sum of 2 quarters · filed 2015-03-09 | $5.06M derived: sum of 3 quarters · filed 2015-03-09 | $6.32M 10-K · filed 2015-03-09 |
| 2013-09-30 | $1.25M 10-Q · filed 2014-11-10 | $2.29M derived: sum of 2 quarters · filed 2014-11-10 | $3.55M 10-Q · filed 2014-11-10 | $5.21M derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $1.04M 10-Q · filed 2014-08-01 | $2.30M 10-Q · filed 2014-08-01 | $3.96M derived: sum of 3 quarters · filed 2014-08-01 | $5.12M derived: sum of 4 quarters · filed 2014-08-01 |
| 2013-03-31 | $1.26M 10-Q · filed 2014-05-05 | $2.92M derived: sum of 2 quarters · filed 2014-05-05 | $4.07M derived: sum of 3 quarters · filed 2014-05-05 | $5.17M derived: sum of 4 quarters · filed 2014-05-05 |
| 2012-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $2.81M derived: sum of 2 quarters · filed 2014-03-11 | $3.91M derived: sum of 3 quarters · filed 2014-03-11 | $5.36M 10-K · filed 2014-03-11 |
| 2012-09-30 | $1.15M 10-Q · filed 2013-11-12 | $2.25M derived: sum of 2 quarters · filed 2013-11-12 | $3.69M 10-Q · filed 2013-11-12 | $6.44M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $1.10M 10-Q · filed 2013-08-13 | $2.54M 10-Q · filed 2013-08-13 | $5.29M derived: sum of 3 quarters · filed 2013-08-13 | $7.92M derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $1.44M 10-Q · filed 2013-05-13 | $4.19M derived: sum of 2 quarters · filed 2013-05-13 | $6.82M derived: sum of 3 quarters · filed 2013-05-13 | $8.48M derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $5.37M derived: sum of 2 quarters · filed 2013-03-28 | $7.04M derived: sum of 3 quarters · filed 2013-03-28 | $7.84M 10-K · filed 2013-03-28 |
| 2011-09-30 | $2.63M 10-Q · filed 2012-11-14 | $4.29M derived: sum of 2 quarters · filed 2012-11-14 | $5.09M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $1.67M 10-Q · filed 2012-08-08 | $3.07M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $1.37M 10-Q · filed 2012-05-21 | |||
| 2010-12-31 | $3.85M 10-K · filed 2012-03-16 | |||
| 2009-12-31 | $358.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |